Atlas Trials

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Clinical trial NCT03033225 · COMPLETED

Trial details

NCT number
NCT03033225
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Pancreatic CarcinomaLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaPancreatic NeoplasmStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Unresectable Pancreatic Carcinoma
Start date
2017-05-31
Primary completion
2023-09-20
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.